Viomi Technology Co., Ltd ("Viomi" or the "Company") (NASDAQ: VIOT), a leading technology company for home water solutions in China, today announced ...

H1 total sales growth of 11.4% at CER1, or 9.7% as reported, driven by the three therapeutic areas: 95.7% in Rare Disease, 9.7% in Neuroscience, and 6.4% in OncologyH1 core operating income of €656m, ...

SYENSQO SECOND QUARTER 2025 RESULTS July 31, 2025 7.00 a.m. CEST UNDERLYING EBITDA OF €335 MILLION INCREASED 8% SEQUENTIALLY WITH IMPROVED MARGIN IN CORE SEGMENTS FY 2025 OUTLOOK UPDATED FOR ...